Work

Molecular and genomic predictors of response to single-agent doxorubicin (ADR) versus single-agent docetaxel (DOC) in primary breast cancer (PBC).

Year: 2010

Type: conference-abstract

Source: Journal of Clinical Oncology

DOI: 10.1200/jco.2010.28.15_suppl.502

Authors: M. Martin, A. Romero, J. Lopez Garcia-Asenjo, M. C. Cheang, B. Oliva, J. Garcia Saenz, X. He, T. Caldes, E. Diaz-Rubio, C. M. Perou

Language: English

Topic: Breast Cancer Treatment Studies

Subfield: Cancer Research

Field: Biochemistry, Genetics and Molecular Biology

Domain: Life Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W2278793543

Cites:

Cited by: 11

Related to: 10